FRANZETTI, MARCO
FRANZETTI, MARCO
Universita' degli Studi di MILANO
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort
2024 A. Soria, F. Graziano, G. Ghilardi, G. Lapadula, D.D. Gasperina, S.V. Benatti, E. Quiros-Roldan, M. Milesi, F. Bai, M. Merli, D. Minisci, M. Franzetti, E. Asperges, F. Chiabrando, D. Pocaterra, A. Pandolfo, F. Zanini, D. Lombardi, A. Cappelletti, A. Rugova, M.L. Borghesi, N. Squillace, L. Pusterla, S. Piconi, P. Morelli, P.R. Querini, R. Bruno, S. Rusconi, S. Casari, A. Bandera, F. Franzetti, G. Travi, A. D'Arminio Monforte, G. Marchetti, A. Pan, F. Castelli, M. Rizzi, F. Dentali, M. Mallardo, E. Rossi, M.G. Valsecchi, S. Galimberti, P. Bonfanti
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan
2020 A. Lai, A. Bergna, F.R. Simonetti, M. Franzetti, G. Bozzi, V. Micheli, C. Aztori, A. Ridolfo, G. Zehender, M. Ciccozzi, M. Galli, C. Balotta
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference
2019 A. Giacomelli, A. Lai, M. Franzetti, F. Maggiolo, S. Di Giambenedetto, V. Borghi, D. Francisci, G. Magnani, M. Pecorari, L. Monno, I. Vicenti, L. Lepore, F. Lombardi, S. Paolucci, S. Rusconi
Gastrointestinal basidiobolomycosis: an emerging mycosis difficult to diagnose but curable: Case report and review of the literature
2019 M.D. Pezzani, V. Di Cristo, C. Parravicini, A. Sonzogni, C. Tonello, M. Franzetti, S. Sollima, M. Corbellino, M. Galli, L. Milazzo, S. Antinori
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors : results from a large observational cohort study (SCOLTA)
2018 L. Taramasso, P. Tatarelli, E. Ricci, G. Madeddu, B. Menzaghi, N. Squillace, G.V. De Socio, C. Martinelli, R. Gulminetti, P. Maggi, G. Orofino, F. Vichi, A. Di Biagio, P. Bonfanti, C. Bellacosa, L. Calza, C. Abeli, B.M. Celesia, C. Grosso, A. Stagno, F. Mazzotta, G. Penco, G. Cassola, L.A. Nicolini, C. Dentone, C. Molteni, L. Palvarini, A. Scalzini, L. Carenzi, G. Rizzardini, L. Valsecchi, L. Cordier, S. Rusconi, V. Colombo, M. Galli, M. Franzetti, A. Sgrelli, E. Mazzotta, G. Parruti, P. Bagella, M.S. Mura, R. Libertone, A. Antinori, S. Di Giambenedetto, M. Guastavigna, P. Caramello
A Simple model of HIV epidemic in Italy: The role of the antiretroviral treatment
2018 F. Papa, F. Binda, G. Felici, M. Franzetti, A. Gandolfi, C. Sinisgalli, C. Balotta
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period : a weighted analysis
2018 M. Franzetti, A. De Luca, F. Ceccherini-Silberstein, V. Spagnuolo, E. Nicastri, C. Mussini, A. Antinori, L. Monno, J. Vecchiet, I. Fanti, A. d'Arminio Monforte, C. Balotta
Bilateral choroiditis as the only sign of persistent Mycobacterium intracellulare infection following haematogenous spread in an immunocompromised patient
2017 A. Invernizzi, D. Ricaboni, M. Franzetti, G. Staurenghi, P. Mccluskey, F. Franzetti
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients
2016 A. Giacomelli, L. Oreni, M. Franzetti, V. Di Cristo, E. Colella, A.L. Ridolfo, M. Galli, S. Rusconi
Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial
2016 L. Galli, V. Spagnuolo, A. Bigoloni, A.D. Monforte, F. Montella, A. Antinori, A. Di Biagio, S. Rusconi, G. Guaraldi, S. Di Giambenedetto, M. Borderi, D. Gibellini, G. Caramatti, A. Lazzarin, A. Castagna, C. Viscoli, A. Di Biagio, A. Parisini, R. Prinapori, F. Mazzotta, S. Lo Caputo, M. Di Pietro, C. Tincati, T. Bini, E. Merlini, M. Puoti, M. Moioli, M. Montella, F. Di Sora, A. Antinori, A. Ammassari, S. Ottou, R. Cauda, S. Di Giambenedetto, M. Galli, S. Rusconi, M. Franzetti, G. Rizzardini, A. Capetti, A. Castagna, V. Spagnuolo, S. Nozza, N. Gianotti, P. Cinque, S. Gerevini, F. Ferretti, A. Lazzarin, L. Galli, E. Carini, A. Bigoloni, C. Vinci, A. Galli, S. Salpietro, A. Poli, C. Mussini, G. Guaraldi
Local and global spatio-temporal dynamics of HIV-1 subtype F1
2014 A. Lai, M. Ciccozzi, M. Franzetti, F.R. Simonetti, G. Bozzi, F. Binda, A. Rosi, S. Bonora, A. De Luca, C. Balotta, G. Zehender
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy
2014 M. Franzetti, F. Adorni, L. Oreni, L. van Den Bogaart, C. Resnati, L. Milazzo, S. Antinori, M. Galli, A.L. Ridolfo
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy
2014 M. Franzetti, M. Violin, A. Antinori, A. De Luca, F. Ceccherini Silberstein, N. Gianotti, C. Torti, S. Bonora, M. Zazzi, C. Balotta
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens
2014 A. Giacomelli, L. Oreni, M. Franzetti, V. Di Cristo, B. Vergani, M. Morosi, E. Colella, M. Galli, S. Rusconi
Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics
2014 A. Lai, G. Bozzi, M. Franzetti, F. Binda, F.R. Simonetti, V. Micheli, P. Meraviglia, P. Corsi, P. Bagnarelli, A. De Luca, M. Ciccozzi, G. Zehender, M. Zazzi, C. Balotta
Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-Institution retrospective study before and after the introduction of HAART
2013 M. Franzetti, F. Adorni, C. Parravicini, B. Vergani, S. Antinori, L. Milazzo, M. Galli, A.L. Ridolfo
EVALUATION OF VIROLOGICAL RESPONSE TO ANTIRETROVIRAL THERAPY IN PATIENTS CARRYING HIV-1 NON-B SUBTYPES ACCORDING TO BASELINE MUTATIONAL PATTERNS
2013 M. Franzetti
Transmission of Resistant HIV-1 Variants and Epidemiological Chains in Italian Newly Diagnosed Individuals
2012 A. Lai, M. Violin, E. Ebranati, M. Franzetti, V. Micheli, M.R. Gismondo, A. Capetti, P. Meraviglia, F.R. Simonetti, G. Bozzi, M. Ciccozzi, M. Galli, G. Zehender, C. Balotta
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients
2012 A. Giacomelli, M. Franzetti, B. Vergani, L. Oreni, M. Morosi, V. Di Cristo, E. Colella, O. Viganò, M. Galli, S. Rusconi
Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy
2012 M. Franzetti, M. Violin, G. Casazza, G. Meini, A. Callegaro, P. Corsi, F. Maggiolo, A.R. Pignataro, S. Paolucci, N. Gianotti, D. Francisci, R. Rossotti, G. Filice, T. Carli, M. Zazzi, C. Balotta